Ipamorelin + CJC-1295 (No DAC) (5MG / 5MG) Analytical Reference Material (In Vitro Research Only)
A research combination of two peptides that act on different receptors in pituitary cells: Ipamorelin (5 mg), which activates the ghrelin receptor (GHS-R1a), and CJC-1295 No DAC (5 mg), a modified fragment of growth-hormone-releasing hormone. Published cell-culture work has studied how each one drives growth hormone signaling. Each component is listed separately below.
2:00 PM PST Same-Day Laboratory Dispatch · Free Shipping Over $300
1:1 Analytical & Chemical Specifications
| Analytical Parameter | Verified Specification |
|---|---|
| CAS Number | Ipamorelin: 170851-70-4 | CJC-1295 No DAC (Mod GRF 1-29): 863288-34-0 |
| Molecular Formula | Ipamorelin: C38H49N9O5 | CJC-1295 No DAC (Mod GRF 1-29): C152H252N44O42 |
| Molecular Weight | Ipamorelin: 711.86 g/mol | CJC-1295 No DAC (Mod GRF 1-29): 3367.97 g/mol |
| Amino Acid Sequence | Ipamorelin (5mg): Aib-His-D-2Nal-D-Phe-Lys-NH2 | CJC-1295 No DAC (Mod GRF 1-29) (5mg): Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-NH2 |
| Chromatographic Purity (RP-HPLC) | >=99.0% Peak Area (Observed Lot 2026IPACJ10B: 99.4%) |
| Identity Verification | Electrospray Ionization Mass Spectrometry (ESI-MS) |
| Physical Form | Lyophilized Powder in Sealed Desiccated Glass Vial |
| Recommended Storage | -20°C Desiccated & Protected from Light |
| Regulatory Classification | Research Use Only (RUO) — Not a 503A Compounding Pharmacy Product; Strictly Not for Human or Veterinary Use |
| Lot Traceability | Lot 2026IPACJ10B (Tested 2026-03-10) — Verify Dataset in COA Library → |
| Blend Component Breakdown | |
| Ipamorelin (5mg) |
MW: 711.86 g/mol
CAS: 170851-70-4
Seq: Aib-His-D-2Nal-D-Phe-Lys-NH2
|
| CJC-1295 No DAC (Mod GRF 1-29) (5mg) |
MW: 3367.97 g/mol
CAS: 863288-34-0
Seq: Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-NH2
|
Lot-Specific Certificate of Analysis (COA)
In Vitro Laboratory Research Scope
Typical laboratory uses: comparing how pituitary cell cultures respond to ghrelin-receptor and GHRH-receptor activation, including cAMP and calcium signaling. For in-vitro laboratory research only. Not for human or animal use.
Analytical Verification & Storage Parameters for Ipamorelin + CJC-1295 (No DAC)
How is the chromatographic purity of Ipamorelin + CJC-1295 (No DAC) (5MG / 5MG) verified?
Every production batch of Ipamorelin + CJC-1295 (No DAC) (5MG / 5MG), including active Lot 2026IPACJ10B, undergoes independent Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) with UV/Vis detection at 214 nm and Electrospray Ionization Mass Spectrometry (ESI-MS), confirming 99.4% peak area purity (retention time 10.95 min) and exact molecular mass concordance prior to catalog release.
What are the laboratory storage and stability parameters for lyophilized Ipamorelin + CJC-1295 (No DAC)?
Lyophilized Ipamorelin + CJC-1295 (No DAC) reference material is supplied in a sealed, desiccated borosilicate glass vial under inert atmosphere and must be stored at -20°C protected from light to prevent hydrolytic or oxidative cleavage. Once solubilized in sterile aqueous buffer for in vitro assays, maintain aliquots at 2°C to 8°C and avoid repeated freeze-thaw cycles.
What are the chemical identifiers and regulatory classification of Ipamorelin + CJC-1295 (No DAC)?
Ipamorelin + CJC-1295 (No DAC) is characterized by CAS Registry identifier Ipamorelin: 170851-70-4 | CJC-1295 No DAC (Mod GRF 1-29): 863288-34-0, molecular formula Ipamorelin: C38H49N9O5 | CJC-1295 No DAC (Mod GRF 1-29): C152H252N44O42, and theoretical molecular weight Ipamorelin: 711.86 g/mol | CJC-1295 No DAC (Mod GRF 1-29): 3367.97 g/mol. Regenerative Health Peptides supplies this reagent strictly as a Research Use Only (RUO) analytical reference material for qualified 21+ in vitro laboratory investigations, never for human or veterinary use.
Primary Scientific Literature & Preclinical Citations
Peer-ReviewedThe following peer-reviewed scientific publications report preclinical investigations into the biochemical mechanisms and receptor pharmacology of this compound. Regenerative Health Peptides supplies this material strictly for in-vitro laboratory research.
Laboratory Testing Guides & Documentation
View All Guides →Similar Research Peptides
CJC-1295 (No DAC)
CJC-1295 (No DAC), also called Modified GRF 1-29, is a 29-amino-acid synthetic fragment of growth-hormone-releasing…
Sermorelin
Sermorelin is a 29-amino-acid fragment (GRF 1-29) of human growth-hormone-releasing hormone. Published work reported that…
TH9507
TH9507 is the research designation for tesamorelin, a synthetic 44-amino-acid version of growth-hormone-releasing hormone (GHRH)…
Ipamorelin
Ipamorelin is a five-amino-acid synthetic peptide that selectively activates the growth hormone secretagogue receptor (GHS-R1a,…
